Webcast

Nyrada Investor Briefing – 24 June

June 24, 2020

Nyrada Investor Briefing – 24 June

Nyrada Inc. (ASX: NYR) Webcast Replay

Nyrada Inc. (ASX: NYR) is a preclinical stage, drug discovery and development company, specialising in novel small molecule drugs to treat cardiovascular, neurological, and inflammatory diseases..

As a part of our ‘Meet the CEOs’ series, CEO James Bonnar provides valuable insights to the company, its key markets and industry, and future prospects.

Recorded on 24th June 2020 at 12pm (AEST).

Join the next Meet the CEOs webcast

Speak to our Advisor team about this company

FEATURE SPEAKERS

James Bonnar

Chief Executive Officer

Nyrada Inc. (ASX: NYR) is a preclinical stage, drug discovery and development company, specialising in novel small molecule drugs to treat cardiovascular, neurological, and inflammatory diseases. The Company has two main programs, each targeting market sectors of significant size and considerable unmet clinical need.

Speak to our Advisor team about this company



By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.